Skip to main content

Search

27 result(s) for 'author#Yudi Pawitan' within BMC

Page 1 of 2

Sort by: Relevance | Date

  1. Metastasis is the primary cause of death for cancer patients. TWIST1, an evolutionarily conserved basic helix-loop-helix (bHLH) transcription factor, is a strong promoter of metastatic spread and its expressio...

    Authors: Shan Li, Stephen E Kendall, Raquel Raices, James Finlay, Maricela Covarrubias, Zheng Liu, Gina Lowe, Yu-Huey Lin, Yuan Han Teh, Victoria Leigh, Simi Dhillon, Steven Flanagan, Karen S Aboody and Carlotta A Glackin
    Citation: BMC Biology 2012 10:73
  2. Postmenopausal hormone-replacement therapy (HRT) increases breast-cancer risk. The influence of HRT on the biology of the primary tumor, however, is not well understood.

    Authors: Per Hall, Alexander Ploner, Judith Bjöhle, Fei Huang, Chin-Yo Lin, Edison T Liu, Lance D Miller, Hans Nordgren, Yudi Pawitan, Peter Shaw, Lambert Skoog, Johanna Smeds, Sara Wedrén, John Öhd and Jonas Bergh
    Citation: BMC Medicine 2006 4:16
  3. Protein-based breast cancer biomarkers are a promising resource for breast cancer detection at the earliest and most treatable stages of the disease. Plasma is well suited to proteomic-based methods of biomark...

    Authors: Michael A Davis and Samir Hanash
    Citation: Breast Cancer Research 2006 8:217
  4. Gene expression profiling is a relatively new technology for the study of breast cancers, but within the past few years there has been a rapid rise in interest in its potential to improve the clinical manageme...

    Authors: Andrew H Sims, Kai Ren Ong, Robert B Clarke and Anthony Howell
    Citation: Breast Cancer Research 2006 8:214
  5. It is generally accepted that early detection of breast cancer has great impact on patient survival, emphasizing the importance of early diagnosis. In a widely recognized model of breast cancer development, tu...

    Authors: Karin Rennstam and Ingrid Hedenfalk
    Citation: Breast Cancer Research 2006 8:213
  6. Candidate polymorphism-based genetic epidemiological studies have yielded little success in the search for low-penetrance breast cancer susceptibility genes. The lack of progress is partially due to insufficie...

    Authors: Yen-Ling Low, Sara Wedrén and Jianjun Liu
    Citation: Breast Cancer Research 2006 8:209
  7. Non-small cell lung cancer (NSCLC), a leading cause of cancer deaths, represents a heterogeneous group of neoplasms, mostly comprising squamous cell carcinoma (SCC), adenocarcinoma (AC) and large-cell carcinom...

    Authors: Vladimir Lazar, Chen Suo, Cedric Orear, Joost van den Oord, Zsofia Balogh, Justine Guegan, Bastien Job, Guillaume Meurice, Hugues Ripoche, Stefano Calza, Johanna Hasmats, Joakim Lundeberg, Ludovic Lacroix, Philippe Vielh, Fabienne Dufour, Janne Lehtiö…
    Citation: BMC Medical Genomics 2013 6:53
  8. From 1968 to 2002, Singapore experienced an almost four-fold increase in prostate cancer incidence. This paper examines the incidence, mortality and survival patterns for prostate cancer among all residents in...

    Authors: Sin Eng Chia, Chuen Seng Tan, Gek Hsiang Lim, Xueling Sim, Yudi Pawitan, Marie Reilly, Safiyya Mohamed Ali, Weber Lau and Kee Seng Chia
    Citation: BMC Cancer 2008 8:368
  9. Adjuvant breast cancer therapy significantly improves survival, but overtreatment and undertreatment are major problems. Breast cancer expression profiling has so far mainly been used to identify women with a ...

    Authors: Yudi Pawitan, Judith Bjöhle, Lukas Amler, Anna-Lena Borg, Suzanne Egyhazi, Per Hall, Xia Han, Lars Holmberg, Fei Huang, Sigrid Klaar, Edison T Liu, Lance Miller, Hans Nordgren, Alexander Ploner, Kerstin Sandelin, Peter M Shaw…
    Citation: Breast Cancer Research 2005 7:R953
  10. Neuroblastoma is the most common pediatric malignancy with heterogeneous clinical behaviors, ranging from spontaneous regression to aggressive progression. Many studies have identified aberrations related to t...

    Authors: Chen Suo, Wenjiang Deng, Trung Nghia Vu, Mingrui Li, Leming Shi and Yudi Pawitan
    Citation: Biology Direct 2018 13:14
  11. Current prostate cancer prognostic models are based on pre-treatment prostate specific antigen (PSA) levels, biopsy Gleason score, and clinical staging but in practice are inadequate to accurately predict dise...

    Authors: Andrea Sboner, Francesca Demichelis, Stefano Calza, Yudi Pawitan, Sunita R Setlur, Yujin Hoshida, Sven Perner, Hans-Olov Adami, Katja Fall, Lorelei A Mucci, Philip W Kantoff, Meir Stampfer, Swen-Olof Andersson, Eberhard Varenhorst, Jan-Erik Johansson, Mark B Gerstein…
    Citation: BMC Medical Genomics 2010 3:8
  12. Aspirin (ASA) use has been associated with improved breast cancer survival in several prospective studies.

    Authors: Michelle D Holmes, Henrik Olsson, Yudi Pawitan, Johanna Holm, Cecilia Lundholm, Therese M-L Andersson, Hans-Olov Adami, Johan Askling and Karin Ekström Smedby
    Citation: BMC Cancer 2014 14:391
  13. Molecular markers and the rich biological information they contain have great potential for cancer diagnosis, prognostication and therapy prediction. So far, however, they have not superseded routine histopath...

    Authors: Stefano Calza, Per Hall, Gert Auer, Judith Bjöhle, Sigrid Klaar, Ulrike Kronenwett, Edison T Liu, Lance Miller, Alexander Ploner, Johanna Smeds, Jonas Bergh and Yudi Pawitan
    Citation: Breast Cancer Research 2006 8:R34
  14. There are currently a number of competing techniques for low-level processing of oligonucleotide array data. The choice of technique has a profound effect on subsequent statistical analyses, but there is no me...

    Authors: Alexander Ploner, Lance D Miller, Per Hall, Jonas Bergh and Yudi Pawitan
    Citation: BMC Bioinformatics 2005 6:80
  15. Gene-set enrichment analyses (GEA or GSEA) are commonly used for biological characterization of an experimental gene-set. This is done by finding known functional categories, such as pathways or Gene Ontology ...

    Authors: Andrey Alexeyenko, Woojoo Lee, Maria Pernemalm, Justin Guegan, Philippe Dessen, Vladimir Lazar, Janne Lehtiö and Yudi Pawitan
    Citation: BMC Bioinformatics 2012 13:226
  16. Algorithms and software for CNV detection have been developed, but they detect the CNV regions sample-by-sample with individual-specific breakpoints, while common CNV regions are likely to occur at the same ge...

    Authors: Teo Shu Mei, Agus Salim, Stefano Calza, Ku Chee Seng, Chia Kee Seng and Yudi Pawitan
    Citation: BMC Bioinformatics 2010 11:147
  17. Circular RNA (circRNA) is an emerging class of RNA molecules attracting researchers due to its potential for serving as markers for diagnosis, prognosis, or therapeutic targets of cancer, cardiovascular, and a...

    Authors: Dat Thanh Nguyen, Quang Thinh Trac, Thi-Hau Nguyen, Ha-Nam Nguyen, Nir Ohad, Yudi Pawitan and Trung Nghia Vu
    Citation: BMC Bioinformatics 2021 22:495
  18. Joint analysis of transcriptomic and proteomic data taken from the same samples has the potential to elucidate complex biological mechanisms. Most current methods that integrate these datasets allow for the co...

    Authors: Chuen Seng Tan, Agus Salim, Alexander Ploner, Janne Lehtiö, Kee Seng Chia and Yudi Pawitan
    Citation: BMC Bioinformatics 2009 10:272
  19. Most mammography screening programs are not individualized. To efficiently screen for breast cancer, the individual risk of the disease should be determined. We describe a model that could be used at most mamm...

    Authors: Mikael Eriksson, Kamila Czene, Yudi Pawitan, Karin Leifland, Hatef Darabi and Per Hall
    Citation: Breast Cancer Research 2017 19:29